ArticleMacromolecular rapid communications2025
Furan-Protected 4-Maleimidomethyl Styrene for Reversible Crosslinked Polymers.
Article in Macromolecular rapid communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Furan-Protected 4-Maleimidomethyl Styrene for Reversible Crosslinked Polymers.Macromolecular rapid communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Due to the growing interest in reversibly cross-linkable polymers, the synthesis of maleimide-containing polymers for Diels-Alder crosslinking is very attractive. Here we present two new synthetic approaches to such polymers, starting from an N-alkylation of furane-protected maleimide, either at the polymeric level with poly(styrene-stat-4-chloromethylstyrene) or at the level of monomeric structures with 4-chloromethylstyrene. Both strategies allow freely adjustable maleimide contents and copolymerization with various comonomers. The monomer used for the second route has not yet been described in this form and is therefore examined in more detail, particularly with regard to its copolymerization behavior. We also present the reversibility of the cross-linking reaction and the possibility of integrating further functional groups into the polymer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.